Extracellular calumenin suppresses ERK1/2 signaling and cell migration by protecting fibulin-1 from MMP-13-mediated proteolysis

Oncogene

Volumn 34, Issue 8, 2015, Pages 1006-1018

  Wang, Q ^a   Shen, B ^a   Chen, L ^a   Zheng, P ^a   Feng, H ^a   Hao, Q ^a   Liu, X ^a   Liu, L ^a   Xu, S ^a   Chen, J ^a,b   Teng, J ^a  

^a Peking University   (China)

^b PEKING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM BINDING PROTEIN; CALU PROTEIN, MOUSE; COLLAGENASE 3; FIBULIN; MMP13 PROTEIN, MOUSE;

ANIMAL; C57BL MOUSE; CELL MOTION; DOWN REGULATION; EXTRACELLULAR SPACE; FEMALE; GENETICS; HEK293 CELL LINE; HELA CELL LINE; HUMAN; MCF 7 CELL LINE; METABOLISM; MOUSE; PHYSIOLOGY; PROTEIN DEGRADATION; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE; TUMOR CELL CULTURE;

ANIMALS; CALCIUM-BINDING PROTEINS; CELL MOVEMENT; DOWN-REGULATION; EXTRACELLULAR SPACE; FEMALE; HEK293 CELLS; HELA CELLS; HUMANS; MAP KINASE SIGNALING SYSTEM; MATRIX METALLOPROTEINASE 13; MCF-7 CELLS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PROTEOLYSIS; TUMOR CELLS, CULTURED;

EID: 84895911577     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2014.52     Document Type: Article

References (55)

1. Hynes RO. The extracellular matrix: not just pretty fibrils. Science 2009; 326: 1216-1219.
2. Olin AI, Morgelin M, Sasaki T, Timpl R, Heinegard D, Aspberg A. The proteoglycans aggrecan and Versican form networks with fibulin-2 through their lectin domain binding. J Biol Chem 2001; 276: 1253-1261.
3. Roark EF, Keene DR, Haudenschild CC, Godyna S, Little CD, Argraves WS. The association of human fibulin-1 with elastic fibers: an immunohistological, ultrastructural, and RNA study. J Histochem Cytochem 1995; 43: 401-411.
4. Twal WO, Czirok A, Hegedus B, Knaak C, Chintalapudi MR, Okagawa H et al. Fibulin-1 suppression of fibronectin-regulated cell adhesion and motility. J Cell Sci 2001; 114: 4587-4598.
5. Williams SA, Schwarzbauer JE. A shared mechanism of adhesion modulation for tenascin-C and fibulin-1. Mol Biol Cell 2009; 20: 1141-1149.
6. Xie L, Palmsten K, MacDonald B, Kieran MW, Potenta S, Vong S et al. Basement membrane derived fibulin-1 and fibulin-5 function as angiogenesis inhibitors and suppress tumor growth. Exp Biol Med 2008; 233: 155-162.
7. Zhang H, Gao X, Weng C, Xu Z. Interaction between angiogenin and fibulin 1: evidence and implication. Acta Biochimica et Biophysica Sinica 2008; 40: 375-380.
8. Cooley MA, Fresco VM, Dorlon ME, Twal WO, Lee NV, Barth JL et al. Fibulin-1 is required during cardiac ventricular morphogenesis for versican cleavage, suppression of ErbB2 and Erk1/2 activation, and to attenuate trabecular cardiomyocyte proliferation. Dev Dynamics 2012; 241: 303-314.
9. Kessenbrock K, Plaks V, Werb Z. Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 2010; 141: 52-67.
10. Vandenbroucke RE, Dejonckheere E, Van Hauwermeiren F, Lodens S, De Rycke R, Van Wonterghem E et al. Matrix metalloproteinase 13 modulates intestinal epithelial barrier integrity in inflammatory diseases by activating TNF. EMBO Mol Med 2013; 5: 1000-1016.
11. Leeman MF, Curran S, Murray GI. The structure, regulation, and function of human matrix metalloproteinase-13. Crit Rev Biochem Mol Biol 2002; 37: 149-166.
12. Klein T, Bischoff R. Physiology and pathophysiology of matrix metalloproteases. Amino Acids 2011; 41: 271-290.
13. Zigrino P, Kuhn I, Bauerle T, Zamek J, Fox JW, Neumann S et al. Stromal expression of MMP-13 is required for melanoma invasion and metastasis. J Invest Dermatol 2009; 129: 2686-2693.
14. Knauper V, Will H, Lopez-Otin C, Smith B, Atkinson SJ, Stanton H et al. Cellular mechanisms for human procollagenase-3 (MMP-13) activation. Evidence that MT1-MMP (MMP-14) and gelatinase a (MMP-2) are able to generate active enzyme. J Biol Chem 1996; 271: 17124-17131.
15. Honore B. The rapidly expanding CREC protein family: members, localization, function, and role in disease. Bioessays 2009; 31: 262-277.
16. Yabe D, Taniwaki M, Nakamura T, Kanazawa N, Tashiro K, Honjo T. Human calumenin gene (CALU): cDNA isolation and chromosomal mapping to 7q32. Genomics 1998; 49: 331-333.
17. Vorum H, Liu X, Madsen P, Rasmussen HH, Honore B. Molecular cloning of a cDNA encoding human calumenin, expression in Escherichia coli and analysis of its Ca2 +binding activity. Biochim Biophys Acta 1998; 1386: 121-131.
18. Hseu MJ, Yen CH, Tzeng MC. Crocalbin: a new calcium-binding protein that is also a binding protein for crotoxin, a neurotoxic phospholipase A2. FEBS Lett 1999; 445: 440-444.
19. Feng H, Chen L, Wang Q, Shen B, Liu L, Zheng P et al. Calumenin-15 facilitates filopodia formation by promoting TGF-beta superfamily cytokine GDF-15 transcription. Cell Death Dis 2013; 4: e870.
20. Vorum H, Hager H, Christensen BM, Nielsen S, Honore B. Human calumenin localizes to the secretory pathway and is secreted to the medium. Exp Cell Res 1999; 248: 473-481.
21. Wang Q, Feng H, Zheng P, Shen B, Chen L, Liu L et al. The intracellular transport and secretion of calumenin-1/2 in living cells. PLoS One 2012; 7: e35344.
22. Ding SJ, Li Y, Shao XX, Zhou H, Zeng R, Tang ZY et al. Proteome analysis of hepatocellular carcinoma cell strains, MHCC97-H and MHCC97-L, with different metastasis potentials. Proteomics 2004; 4: 982-994.
23. Wu W, Tang X, Hu W, Lotan R, Hong WK, Mao L. Identification and validation of metastasis-associated proteins in head and neck cancer cell lines by two-dimensional electrophoresis and mass spectrometry. Clin Exp Metastasis 2002; 19: 319-326.
24. Shen C, Hui Z, Wang D, Jiang G, Wang J, Zhang G. Molecular cloning, identification and analysis of lung squamous cell carcinoma-related genes. Lung Cancer 2002; 38: 235-241.
25. Kapoor A, Goldberg MS, Cumberland LK, Ratnakumar K, Segura MF, Emanuel PO et al. The histone variant macroH2A suppresses melanoma progression through regulation of CDK8. Nature 2010; 468: 1105-1109.
26. Huang C, Jacobson K, Schaller MD. MAP kinases and cell migration. J Cell Sci 2004; 117: 4619-4628.
27. Duncia JV, Santella 3rd JB, Higley CA, Pitts WJ, Wityak J, Frietze WE et al. MEK inhibitors: the chemistry and biological activity of U0126, its analogs, and cyclization products. Bioorganic Medicinal Chem Lett 1998; 8: 2839-2844.
28. Mendoza MC, Er EE, Zhang W, Ballif BA, Elliott HL, Danuser G et al. ERK-MAPK drives lamellipodia protrusion by activating the WAVE2 regulatory complex. Mol Cell 2011; 41: 661-671.
29. Martinez-Quiles N, Ho HY, Kirschner MW, Ramesh N, Geha RS. Erk/Src phosphorylation of cortactin acts as a switch on-switch off mechanism that controls its ability to activate N-WASP. Mol Cell Biol 2004; 24: 5269-5280.
30. Cukierman E, Pankov R, Stevens DR, Yamada KM. Taking cell-matrix adhesions to the third dimension. Science 2001; 294: 1708-1712.
31. Pan TC, Kluge M, Zhang RZ, Mayer U, Timpl R, Chu ML. Sequence of extracellular mouse protein BM-90/fibulin and its calcium-dependent binding to other basement-membrane ligands. Eur J Biochem 1993; 215: 733-740.
32. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011; 144: 646-674.
33. Labat-Robert J. Cell-Matrix interactions, the role of fibronectin and integrins. A survey. Pathologie-Biologie 2012; 60: 15-19.
34. Morgan MR, Humphries MJ, Bass MD. Synergistic control of cell adhesion by integrins and syndecans. Nat Rev Mol Cell Biol 2007; 8: 957-969.
35. Morgan MR, Hamidi H, Bass MD, Warwood S, Ballestrem C, Humphries MJ. Syndecan-4 phosphorylation is a control point for integrin recycling. Dev Cell 2013; 24: 472-485.
36. Vizoso FJ, Gonzalez LO, Corte MD, Corte MG, Bongera M, Martinez A et al. Collagenase-3 (MMP-13) expression by inflamed mucosa in inflammatory bowel disease. Scand J Gastroenterol 2006; 41: 1050-1055.
37. Julovi SM, Ito H, Nishitani K, Jackson CJ, Nakamura T. Hyaluronan inhibits matrix metalloproteinase-13 in human arthritic chondrocytes via CD44 and P38. J Orthopaedic Res 2011; 29: 258-264.
38. Jones CB, Sane DC, Herrington DM. Matrix metalloproteinases: a review of their structure and role in acute coronary syndrome. Cardiovasc Res 2003; 59: 812-823.
39. Zhang X, Chen CT, Bhargava M, Torzilli PA. A. Comparative study of fibronectin cleavage by MMP-1,-3,-13, and-14. Cartilage 2012; 3: 267-277.
40. Turk BE, Huang LL, Piro ET, Cantley LC. Determination of protease cleavage site motifs using mixture-based oriented peptide libraries. Nat Biotechnol 2001; 19: 661-667.
41. Kanda M, Nomoto S, Okamura Y, Hayashi M, Hishida M, Fujii T et al. Promoter hypermethylation of fibulin 1 gene is associated with tumor progression in hepatocellular carcinoma. Mol Carcinogenesis 2011; 50: 571-579.
42. Mikula M, Rubel T, Karczmarski J, Goryca K, Dadlez M, Ostrowski J. Integrating proteomic and transcriptomic high-throughput surveys for search of new biomarkers of colon tumors. Funct Integr Genomics 2010.
43. Voisin SN, Krakovska O, Matta A, Desouza LV, Romaschin AD, Colgan TJ et al. Identification of novel molecular targets for endometrial cancer using a drill-down LC-MS/MS approach with iTRAQ. PLoS One 2010; 6: e16352.
44. Roger P, Pujol P, Lucas A, Baldet P, Rochefort H. Increased immunostaining of fibulin-1, an estrogen-regulated protein in the stroma of human ovarian epithelial tumors. Am J Pathol 1998; 153: 1579-1588.
45. Pupa SM, Argraves WS, Forti S, Casalini P, Berno V, Agresti R et al. Immunological and pathobiological roles of fibulin-1 in breast cancer. Oncogene 2004; 23: 2153-2160.
46. Moll F, Katsaros D, Lazennec G, Hellio N, Roger P, Giacalone PL et al. Estrogen induction and overexpression of fibulin-1C mRNA in ovarian cancer cells. Oncogene 2002; 21: 1097-1107.
47. Lu J, Guo H, Treekitkarnmongkol W, Li P, Zhang J, Shi B et al. 14-3-3zeta Cooperates with ErbB2 to promote ductal carcinoma in situ progression to invasive breast cancer by inducing epithelial-mesenchymal transition. Cancer Cell 2009; 16: 195-207.
48. Wang X, Song X, Zhuo W, Fu Y, Shi H, Liang Y et al. The regulatory mechanism of Hsp90alpha secretion and its function in tumor malignancy. Proc Natl Acad Sci USA 2009; 106: 21288-21293.
49. Lu Y, Xiong Y, Huo Y, Han J, Yang X, Zhang R et al. Grb-2-associated binder 1 (Gab1) regulates postnatal ischemic and VEGF-induced angiogenesis through the protein kinase A-endothelial NOS pathway. Proc Natl Acad Sci USA 2011; 108: 2957-2962.
50. Yang M, Baranov E, Jiang P, Sun FX, Li XM, Li L et al. Whole-body optical imaging of green fluorescent protein-expressing tumors and metastases. Proc Natl Acad Sci USA 2000; 97: 1206-1211.
51. Wang Q, Shen B, Zheng P, Feng H, Chen L, Zhang J et al. Silkworm coatomers and their role in tube expansion of posterior silkgland. PLoS One 2010; 5: e13252.
52. Teng J, Rai T, Tanaka Y, Takei Y, Nakata T, Hirasawa M et al. The KIF3 motor transports N-cadherin and organizes the developing neuroepithelium. Nat Cell Biol 2005; 7: 474-482.
53. Wang Q, Teng J, Shen B, Zhang W, Guo Y, Su X et al. Characterization of kinesinlike proteins in silkworm posterior silkgland cells. Cell Res 2010; 20: 713-727.
54. Wang Q, Chen L, Shen B, Liu Y, Chen J, Teng J. The tau-like protein in silkworm (Bombyx mori) induces microtubule bundle formation. Front Biosci (Elite Ed) 2012; 4: 998-1008.
55. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25: 402-408.